CRIS Executive Compensation

* In USD (Original Currency)
Filing Date
(SEC Report) 		Year Reporting Name Salary Bonus Stock Award Incentive Plan Compensation Other Compensation Total
2024-04-10 2023 Jonathan B. Zung, Ph.D. Chief Development Officer 317,115 0 0 215,600 0 882,415
2023-04-11 2022 Diantha Duvall Chief Financial Officer 209,760 0 0 61,793 10,304 786,109
2022-04-13 2020 Robert E. Martell, M.D., Ph.D. Head of Research and Development 366,091 0 0 261,954 11,401 961,345
2022-04-13 2021 James E. Dentzer President and Chief Executive Officer 590,212 0 0 378,780 21,039 3,390,187
2022-04-13 2019 William E. Steinkrauss Chief Financial Officer 284,301 0 0 91,501 65,488 690,165
2022-04-13 2020 James E. Dentzer President and Chief Executive Officer 554,900 0 0 476,685 14,189 1,672,849
2022-04-13 2021 Robert E. Martell, M.D., Ph.D. Head of Research and Development 370,508 0 0 198,186 17,400 1,502,517
2022-04-13 2020 William E. Steinkrauss Chief Financial Officer 352,135 0 0 201,960 15,761 891,755
2022-04-13 2021 William E. Steinkrauss Chief Financial Officer 400,231 0 0 171,200 18,838 1,899,445
2022-04-13 2019 James E. Dentzer President and Chief Executive Officer 509,507 0 0 183,547 15,206 1,557,773
2022-04-13 2019 Robert E. Martell, M.D., Ph.D. Head of Research and Development 342,245 0 0 128,429 11,200 776,494
2021-04-14 2020 James E. Dentzer President and Chief Executive Officer 544,900 0 0 476,685 14,189 1,672,849
2021-04-14 2018 James E. Dentzer President and Chief Executive Officer 479,383 0 142,313 297,000 14,635 1,964,736
2021-04-14 2020 Robert E. Martell, M.D., Ph.D. Head of Research and Development 366,091 0 0 261,954 11,401 961,345
2021-04-14 2019 Robert E. Martell, M.D., Ph.D. Head of Research and Development 342,245 0 0 128,429 11,200 776,494
2021-04-14 2018 Robert E. Martell, M.D., Ph.D. Head of Research and Development 186,712 0 127,650 124,688 26,042 940,469
2021-04-14 2020 William E. Steinkrauss Chief Financial Officer 352,135 0 0 201,960 15,761 891,755
2021-04-14 2019 William E. Steinkrauss Chief Financial Officer 284,301 0 0 91,501 65,488 690,165
2021-04-14 2019 James E. Dentzer President and Chief Executive Officer 509,507 0 0 183,547 15,206 1,557,773
2020-04-22 2019 James E. Dentzer President and Chief Executive Officer 509,507 0 0 183,547 15,206 1,557,773
2020-04-22 2019 Robert E. Martell, M.D., Ph.D. Head of Research and Development 342,245 0 0 128,429 11,200 776,494
2020-04-22 2018 Robert E. Martell, M.D., Ph.D. Head of Research and Development 186,712 0 127,650 124,688 26,042 940,469
2020-04-22 2019 William E. Steinkrauss 284,301 0 0 91,501 65,488 690,165
2020-04-22 2018 James E. Dentzer President and Chief Executive Officer 479,383 0 142,313 297,000 14,635 1,964,736
2020-04-22 2017 James E. Dentzer President and Chief Executive Officer 442,652 0 0 143,500 22,749 1,578,961
2019-04-11 2018 Robert E. Martell, M.D., Ph.D. Head of Research and Development 186,712 0 127,650 124,688 0 914,426
2018-04-03 2015 Ali Fattaey, Ph.D. President and Chief Executive Officer 515,000 0 0 108,923 10,600 2,821,673
2018-04-03 2017 Ali Fattaey, Ph.D. President and Chief Executive Officer 588,805 0 0 286,740 24,964 2,392,909
2018-04-03 2016 Ali Fattaey, Ph.D. President and Chief Executive Officer 527,677 0 0 178,158 10,600 1,882,435
2017-04-04 2016 David Tuck, M.D. Senior Vice President and Chief Medical Officer 371,308 0 0 84,375 10,600 766,043
2017-04-04 2016 James E. Dentzer Chief Financial Officer and Chief Administrative Officer 320,846 0 0 129,000 20,503 2,159,086
2017-04-04 2016 Mani Mohindru, Ph.D. Senior Vice President and Chief Strategy Officer 370,385 0 0 84,375 10,600 781,800
2016-04-05 2013 Michael P. Gray Chief Financial Officer and Chief Business Officer 359,961 0 0 78,750 10,200 728,299
2016-04-05 2014 Michael P. Gray Chief Financial Officer and Chief Business Officer 399,692 0 0 143,390 10,400 822,879
2016-04-05 2015 Michael P. Gray Chief Financial Officer and Chief Business Officer 412,000 0 0 67,774 10,600 802,266
2016-04-05 2013 Ali Fattaey, Ph.D. President and Chief Executive Officer 366,154 0 0 91,695 72,234 1,331,523
2016-04-05 2015 Ali Fattaey, Ph.D. President and Chief Executive Officer 515,000 0 0 108,923 10,600 2,821,673
2016-04-05 2014 Ali Fattaey, Ph.D. President and Chief Executive Officer 464,231 0 0 190,335 81,794 1,555,755
2016-04-05 2013 Jaye Viner, M.D. Executive Vice President, Chief Medical Officer 142,788 0 0 111,464 5,712 1,295,339
2016-04-05 2014 Jaye Viner, M.D. Executive Vice President, Chief Medical Officer 409,731 0 0 146,991 10,400 836,519
2016-04-05 2015 Jaye Viner, M.D. Executive Vice President, Chief Medical Officer 422,300 0 0 69,468 10,600 814,260
2015-04-15 2012 Daniel R. Passeri Former Chief Executive Officer 450,000 0 0 151,875 10,000 1,806,555
2015-04-15 2013 Daniel R. Passeri Former Chief Executive Officer 464,942 0 0 130,781 10,200 1,052,943
2015-04-15 2014 Daniel R. Passeri Former Chief Executive Officer 226,344 0 0 0 0 675,339
2015-04-15 2012 Michael P. Gray Chief Financial Officer and Chief Business Officer 350,000 0 0 91,875 10,000 1,198,550
2015-04-15 2013 Michael P. Gray Chief Financial Officer and Chief Business Officer 359,961 0 0 78,750 10,200 728,299
2015-04-15 2014 Michael P. Gray Chief Financial Officer and Chief Business Officer 399,692 0 0 143,390 10,400 822,879
2014-04-09 2013 Jaye Viner, M.D Executive Vice President, Chief Medical Officer 142,788 0 0 111,464 5,712 1,295,339
2014-04-09 2013 Ali Fattaey, Ph.D. President and Chief Operating Officer 366,154 0 0 91,695 72,234 1,331,523
2013-04-16 2011 Michael P. Gray Chief Financial Officer 300,000 125,000 0 0 9,800 610,700
2013-04-16 2010 Michael P. Gray Chief Financial Officer 295,961 166,667 0 0 7,350 823,481
2013-04-16 2012 Mark W. Noel Vice President, Technology Management and Intellectual Property 225,000 42,188 0 0 9,000 515,124
2013-04-16 2010 Daniel R. Passeri Chief Executive Officer 391,923 200,000 0 0 7,350 1,176,428
2013-04-16 2010 Mark W. Noel Vice President, Technology Management and Intellectual Property 212,900 66,667 0 0 6,387 444,662
2013-04-16 2012 Daniel R. Passeri Chief Executive Officer 450,000 151,875 0 0 10,000 1,806,555
2013-04-16 2011 Daniel R. Passeri Chief Executive Officer 400,000 150,000 0 0 9,800 841,240
2013-04-16 2011 Mark W. Noel Vice President, Technology Management and Intellectual Property 215,000 50,000 0 0 8,600 358,032
2013-04-16 2012 Michael P. Gray Chief Financial Officer 350,000 91,875 0 0 10,000 1,198,550
2012-04-13 2010 Mark W. Noel Vice President, Technology Management and Intellectual Property 212,900 66,667 0 0 6,387 444,662
2012-04-13 2010 Mitchell Keegan Vice President, Development 247,981 66,667 0 0 7,350 408,512
2012-04-13 2011 Mitchell Keegan Vice President, Development 192,308 0 0 0 8,526 285,266
2012-04-13 2009 Changgeng Qian Senior Vice President, Research and Preclinical Development 233,654 0 0 0 18,546 388,046
2012-04-13 2009 Mitchell Keegan Vice President, Development 233,654 0 0 0 12,808 397,936
2012-04-13 2010 Daniel R. Passeri Chief Executive Officer 391,923 200,000 0 0 7,350 1,176,428
2012-04-13 2009 Daniel R. Passeri Chief Executive Officer 311,538 0 0 0 19,000 556,948
2012-04-13 2011 Michael P. Gray Chief Operating Officer and Chief Financial Officer 300,000 125,000 0 0 9,800 610,700
2012-04-13 2009 Mark W. Noel Vice President, Technology Management and Intellectual Property 196,269 0 0 0 14,829 267,701
2012-04-13 2011 Changgeng Qian Senior Vice President, Research and Preclinical Development 275,000 100,000 0 0 9,800 560,700
2012-04-13 2010 Changgeng Qian Senior Vice President, Research and Preclinical Development 270,961 133,333 0 0 7,350 765,147
2012-04-13 2011 Daniel R. Passeri Chief Executive Officer 400,000 150,000 0 0 9,800 841,240
2012-04-13 2010 Michael P. Gray Chief Operating Officer and Chief Financial Officer 295,961 166,667 0 0 7,350 823,481
2012-04-13 2009 Michael P. Gray Chief Operating Officer and Chief Financial Officer 259,615 0 51,423 0 19,000 465,884
2012-04-13 2011 Mark W. Noel Vice President, Technology Management and Intellectual Property 215,000 50,000 0 0 8,600 358,032
2011-04-19 2009 Changgeng Qian Senior Vice President, Research and Preclinical Development 233,654 0 0 0 18,546 388,046
2011-04-19 2008 Mark W. Noel Vice President, Technology Management and Intellectual Property 206,769 0 0 0 0 303,795
2011-04-19 2009 Mark W. Noel Vice President, Technology Management and Intellectual Property 196,269 0 0 0 14,829 267,701
2011-04-19 2010 Mark W. Noel Vice President, Technology Management and Intellectual Property 212,900 66,667 0 0 6,387 444,662
2011-04-19 2008 Michael P. Gray Chief Operating Officer and Chief Financial Officer 292,308 0 10,285 0 0 496,921
2011-04-19 2009 Michael P. Gray Chief Operating Officer and Chief Financial Officer 259,615 0 51,423 0 19,000 465,884
2011-04-19 2010 Michael P. Gray Chief Operating Officer and Chief Financial Officer 295,961 166,667 0 0 7,350 823,481
2011-04-19 2008 Daniel R. Passeri Chief Executive Officer 384,615 0 0 0 0 783,922
2011-04-19 2009 Daniel R. Passeri Chief Executive Officer 311,538 0 0 0 19,000 556,948
2011-04-19 2010 Changgeng Qian Senior Vice President, Research and Preclinical Development 270,961 133,333 0 0 7,350 765,147
2011-04-19 2010 Daniel R. Passeri Chief Executive Officer 391,923 200,000 0 0 7,350 1,176,428
2011-04-19 2008 Changgeng Qian Senior Vice President, Research and Preclinical Development 245,808 0 0 0 0 459,179
2010-04-16 2009 Mitchell Keegan Vice President, Development 233,654 0 0 0 12,808 397,936
2009-04-17 2008 Mark W. Noel, Vice President Technology Management and Intellectual Property 206,769 0 0 0 0 343,321
2009-04-17 2008 Daniel R. Passeri Chief Executive Officer 384,615 0 0 0 0 855,184
2009-04-17 2007 Daniel R. Passeri Chief Executive Officer 355,000 60,000 6,500 0 9,000 1,057,310
2009-04-17 2006 Daniel R. Passeri Chief Executive Officer 332,596 0 9,100 0 8,800 1,045,309
2009-04-17 2008 Michael P. Gray Chief Operating Officer and Chief Financial Officer 292,308 0 10,285 0 0 568,516
2009-04-17 2007 Michael P. Gray Chief Operating Officer and Chief Financial Officer 293,250 40,000 0 0 9,000 771,865
2009-04-17 2006 Michael P. Gray Chief Operating Officer and Chief Financial Officer 272,304 0 0 0 8,800 674,495
2009-04-17 2007 Mark W. Noel, Vice President Technology Management and Intellectual Property 205,500 20,000 0 0 4,660 396,848
2009-04-17 2006 Mark W. Noel, Vice President Technology Management and Intellectual Property 197,827 0 0 0 0 355,185
2009-04-17 2008 Changgeng Qian Vice President, Research and Preclinical Development 245,808 0 0 0 0 467,339
2009-04-17 2007 Changgeng Qian Vice President, Research and Preclinical Development 219,250 40,000 0 0 8,770 440,839
2009-04-17 2006 Changgeng Qian Vice President, Research and Preclinical Development 177,690 8,775 0 0 7,108 308,535
2007-04-13 2006 Mark W. Noel, Vice President Technology Management and Business Development 197,827 0 0 0 0 355,185
2007-04-13 2006 Michael P. Gray Chief Operating Officer and Chief Financial Officer 272,304 0 0 0 8,800 674,495
2007-04-13 2006 Daniel R. Passeri Chief Executive Officer 332,596 0 9,100 0 8,800 1,045,309
2007-04-13 2006 Mary Elizabeth Potthoff Vice President and General Counsel 195,654 0 0 0 7,826 408,378
2007-04-13 2006 Lee L. Rubin, Senior Vice President of Research and Chief Scientific Officer 181,250 0 0 0 25,284 455,480
2006-04-13 2004 Lee L. Rubin Senior Vice President of Research and Chief Scientific Officer 310,000 0 0 0 6,150 316,150
2006-04-13 2003 Lee L. Rubin Senior Vice President of Research and Chief Scientific Officer 305,000 0 0 0 12,000 317,000
2006-04-13 2005 Mark W. Noel Vice President, Technology Management and Business Development 192,846 33,500 0 0 0 226,346
2006-04-13 2004 Mark W. Noel Vice President, Technology Management and Business Development 190,000 0 0 0 0 190,000
2006-04-13 2003 Mark W. Noel Vice President, Technology Management and Business Development 182,500 0 0 0 0 182,500
2006-04-13 2005 Mary Elizabeth Potthoff Vice President, General Counsel 187,846 33,500 0 0 6,300 227,646
2006-04-13 2004 Mary Elizabeth Potthoff Vice President, General Counsel 185,000 0 0 0 5,565 190,565
2006-04-13 2003 Mary Elizabeth Potthoff Vice President, General Counsel 167,500 0 0 0 10,050 177,550
2006-04-13 2005 Daniel R. Passeri President and Chief Executive Officer 368,538 100,000 0 0 6,300 474,838
2006-04-13 2003 Daniel R. Passeri President and Chief Executive Officer 317,500 0 0 0 12,000 329,500
2006-04-13 2004 Daniel R. Passeri President and Chief Executive Officer 360,000 0 0 0 6,150 366,150
2006-04-13 2005 Michael P. Gray Vice President of Finance and Chief Financial Officer 230,692 75,000 0 0 6,300 311,992
2006-04-13 2004 Michael P. Gray Vice President of Finance and Chief Financial Officer 208,216 0 0 0 6,150 214,366
2006-04-13 2003 Michael P. Gray Vice President of Finance and Chief Financial Officer 144,577 10,000 0 0 9,275 163,852
2006-04-13 2005 Lee L. Rubin Senior Vice President of Research and Chief Scientific Officer 318,538 100,000 0 0 6,300 424,838
2005-04-20 2002 Mark W. Noel Vice President, Technology Management and Business Development 171,654 0 0 0 0 171,654
2005-04-20 2003 Mark W. Noel Vice President, Technology Management and Business Development 182,500 0 0 0 0 182,500
2005-04-20 2004 Mark W. Noel Vice President, Technology Management and Business Development 190,000 0 0 0 0 190,000
2005-04-20 2002 Lee L. Rubin Senior Vice President of Research and Chief Scientific Officer 300,000 0 0 0 0 300,000
2005-04-20 2003 Lee L. Rubin Senior Vice President of Research and Chief Scientific Officer 305,000 0 0 0 12,000 317,000
2005-04-20 2004 Lee L. Rubin Senior Vice President of Research and Chief Scientific Officer 310,000 0 0 0 6,150 316,150
2005-04-20 2002 Michael P. Gray Vice President of Finance and Chief Financial Officer 130,577 0 0 0 0 130,577
2005-04-20 2003 Michael P. Gray Vice President of Finance and Chief Financial Officer 144,577 10,000 0 0 9,275 163,852
2005-04-20 2003 Mary Elizabeth Potthoff Vice President, General Counsel 167,500 0 0 0 10,050 177,550
2005-04-20 2004 Mary Elizabeth Potthoff Vice President, General Counsel 185,000 0 0 0 5,565 190,565
2005-04-20 2002 Mary Elizabeth Potthoff Vice President, General Counsel 48,462 0 0 0 0 48,462
2005-04-20 2004 Michael P. Gray Vice President of Finance and Chief Financial Officer 208,216 0 0 0 6,150 214,366
2005-04-20 2002 Daniel R. Passeri President and Chief Executive Officer 297,308 25,000 50,000 0 0 372,308
2005-04-20 2003 Daniel R. Passeri President and Chief Executive Officer 317,500 0 0 0 12,000 329,500
2005-04-20 2004 Daniel R. Passeri President and Chief Executive Officer 360,000 0 0 0 6,150 366,150
2004-04-22 2003 Mark W. Noel Vice President, Technology Management and Business Development 182,500 0 0 0 0 182,500
2004-04-22 2001 Lee L. Rubin Senior Vice President of Research and Chief Scientific Officer 266,558 0 0 0 5,250 271,808
2004-04-22 2002 Lee L. Rubin Senior Vice President of Research and Chief Scientific Officer 300,000 0 0 0 0 300,000
2004-04-22 2003 Lee L. Rubin Senior Vice President of Research and Chief Scientific Officer 305,000 0 0 0 12,000 317,000
2004-04-22 2001 Christopher U. Missling Senior Vice President of Strategic Analysis and Planning 0 0 0 0 0 0
2004-04-22 2002 Christopher U. Missling Senior Vice President of Strategic Analysis and Planning 92,597 0 0 0 19,754 112,351
2004-04-22 2003 Christopher U. Missling Senior Vice President of Strategic Analysis and Planning 230,000 0 0 0 24,265 254,265
2004-04-22 2001 Daniel R. Passeri President and Chief Executive Officer 276,981 0 0 0 21,797 298,778
2004-04-22 2002 Daniel R. Passeri President and Chief Executive Officer 297,308 25,000 50,000 0 0 372,308
2004-04-22 2003 Daniel R. Passeri President and Chief Executive Officer 317,500 0 0 0 12,000 329,500
2004-04-22 2001 Mary Elizabeth Potthoff Vice President, General Counsel 0 0 0 0 0 0
2004-04-22 2002 Mary Elizabeth Potthoff Vice President, General Counsel 48,462 0 0 0 0 48,462
2004-04-22 2003 Mary Elizabeth Potthoff Vice President, General Counsel 167,500 0 0 0 10,050 177,550
2004-04-22 2001 Mark W. Noel Vice President, Technology Management and Business Development 127,385 0 0 0 22,332 149,717
2004-04-22 2002 Mark W. Noel Vice President, Technology Management and Business Development 171,654 0 0 0 0 171,654
2003-04-24 2001 Daniel R. Passeri President and Chief Executive Officer 276,981 0 0 0 21,797 298,778
2003-04-24 2002 Lee L. Rubin Senior Vice President of Research and Chief Scientific Officer 300,000 0 0 0 0 300,000
2003-04-24 2001 Lee L. Rubin Senior Vice President of Research and Chief Scientific Officer 266,558 0 0 0 5,250 271,808
2003-04-24 2000 Lee L. Rubin Senior Vice President of Research and Chief Scientific Officer 232,096 0 0 0 0 232,096
2003-04-24 2002 Mark W. Noel Vice President, Technology Management and Business Development 171,654 0 0 0 0 171,654
2003-04-24 2001 Mark W. Noel Vice President, Technology Management and Business Development 127,385 0 0 0 22,332 149,717
2003-04-24 2000 Mark W. Noel Vice President, Technology Management and Business Development 0 0 0 0 0 0
2003-04-24 2002 Doros Platika Former Chairman 125,798 0 0 0 1,381,391 1,507,189
2003-04-24 2001 Doros Platika Former Chairman 364,942 0 0 0 50,923 415,865
2003-04-24 2000 Doros Platika Former Chairman 335,481 0 0 0 72,774 408,255
2003-04-24 2002 Daniel R. Passeri President and Chief Executive Officer 297,308 25,000 50,000 0 0 372,308
2003-04-24 2000 Daniel R. Passeri President and Chief Executive Officer 41,346 0 0 0 2,518 43,864

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.